Virax Biolabs Group

$Virax Biolabs Group(VRAX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-26-134281  Size: 8 KB 网页链接

$Virax Biolabs Group(VRAX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950130-26-000117  Size: 9 KB 网页链接

$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-26-114283  Act: 34  Size: 67 KB 网页链接

$Virax Biolabs Group(VRAX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-26-113915  Size: 3 KB 网页链接

$Virax Biolabs Group(VRAX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-26-113905  Size: 3 KB 网页链接

$Virax Biolabs Group(VRAX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-26-113909  Size: 8 KB 网页链接

$Virax Biolabs Group(VRAX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-26-113908  Size: 10 KB 网页链接

$Virax Biolabs Group(VRAX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-26-001233  Act: 34  Size: 10 KB 网页链接

$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-26-031750  Act: 34  Size: 5 MB 网页链接

$Virax Biolabs Group(VRAX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-25-338385  Act: 33  Size: 298 KB 网页链接

$Virax Biolabs Group(VRAX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003963  Act: 33  Size: 1 KB 网页链接

$Virax Biolabs Group(VRAX)$ F-3 Registration statement by foreign private issuers Accession Number: 0001193125-25-324805  Act: 33  Size: 653 KB 网页链接

$Virax Biolabs Group(VRAX)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001193125-25-323885  Act: 33  Size: 10 KB 网页链接

$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-25-308079  Act: 34  Size: 1 MB 网页链接

$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-25-305371  Act: 34  Size: 1 MB 网页链接

$Virax Biolabs Group(VRAX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256667  Act: 34  Size: 6 KB 网页链接

$Virax Biolabs Group(VRAX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256666  Act: 34  Size: 6 KB 网页链接

$Virax Biolabs Group(VRAX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256646  Act: 34  Size: 6 KB 网页链接

$Virax Biolabs Group(VRAX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256640  Act: 34  Size: 6 KB 网页链接

$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-100244  Act: 34  Size: 28 KB 网页链接